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Abstract
The most common type of bacterial meningitis in the developed countries is caused by Neisseria
meningitidis bacteria, which cause meningococcal meningitis. Case fatality rate can be between 3%
and 10% in developed countries and as high as 20% in African countries. During epidemics in sub-
Saharan countries, the so-called meningitis belt, the case fatality rate can peak to 70% or higher.
Some people who have bacterial meningitis experience some form of after effects: epilepsy, damaged
eyesight, hearing loss, brain damage. There is no immunity after infection. Approximately on average
10% of the population at any time carry the germs for days, weeks, or months. Carriers can infect
other individuals by close contacts, even though they do not become ill themselves. An age-structured
mathematical model is formulated that enables the understanding of the dynamics of the infection
transmission. The model is used to study the conditions for the stability of the disease-free steady
state (which imply extinction of the disease) and the existence of an endemic state (which leads to
persistence of the disease in the population). The results of the model are applied to identify the
contribution of the carriers to the transmission of the disease. Final epidemiological conclusions are
given.
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Meningitis is an inflammation of the meninges, that is the membranes surrounding the
brain and spinal cord. The meninges are composed of 3 components: the dura mater, the
tough membrane that lines the cranial cavity; the arachnoid mater, the middle membrane;
and the pia mater, the innermost membrane. Various different agents can cause meningi-
tis. The most common ones are either bacterial or viral organisms. The presence of these
organisms in the subarachnoid space (the space between the pia mater and the arachnoid
mater occupied by the cerebrospinal fluid) causes an inflammatory reaction which involves
all the structures that lie within or adjacent to these areas. Almost any bacteria gaining en-
trance to the meninges may produce meningitis. Bacterial meningitis is sometimes due to
infection in another part of the body (lungs, ears, nose, throat, sinuses) that spreads into
the meninges.
Three specific types of bacteria account for more than 80 percent of all cases of meningi-
tis: Neisseria meningitidis, which causes meningococcal meningitis, haemophilus influen-
zae that causes Hib meningitis, streptococcus pneumoniae, which causes pneumococcal
meningitis. Neisseria meningitidis is the most common cause of bacterial meningitis. All
three bacteria are found in the environment and can even reside in a person’s nose and res-
piratory system without causing any harm. About 10% of the population carry the germs
for days, weeks, or months without becoming ill. Meningococcal carriage is most preva-
lent in teenagers and young adults, where up to 60% of the carriers are often recorded.
Instead, meningococcal carriage seems particularly low in young children and babies. On
the other hand, invasive meningitis is most common in children between ages of 1 month
and 5 years. It is much less common in adults, unless they have a special risk factor, such
as impaired immune system, chronic ear and nose infections, pneumococcal pneumonia,
sickle cell disease, and others.
Coen et al. [11] have explored the role of Neisseria lactamica bacteria, which are closely
related to meningococcus but do not develop invasive infection. The authors test the hy-
pothesis of a relationship between Neisseria lactamica carriage and meningococcal carriage
and conclude that Neisseria lactamica may inhibit meningococcal carriage and that it could
also act as immunogen against meningococcal carriage.
Initially the disease may produce symptoms similar to flu: fever, feeling unwell. More
specific symptoms will appear very rapidly: vomiting, severe headache, generalized con-
vulsions, a disorder of consciousness (drowsiness, confusion, irritability), dislike of bright
lights, stiffness of the neck. Some form of after effects may be experienced, these may
include: epilepsy, mood swings, damaged eyesight, stiff joints, hearing loss, memory loss,
brain damage. Adults may become desperately ill within 24 hours, and children even
sooner. Meningitis can lead to stupor, coma, and death.
An average European incidence rate was recently estimated to be about 1.5 per 100,000,
with differences between countries, such as 0.6 per 100,000 for France, 5.2 per 100,000 for
the UK, and 14.6 per 100,000 for Ireland [19]. As summarized by Cartwright [6], case fa-
tality rates in the developed countries have been about 70–80% from the first accounts until
the Second World War. The first effective treatments have been recorded at the beginning
of this century, in Germany and in the United States. With such treatments the case fatality
rate dropped to about 25%. It decreased more significantly (from 20 to 10%) in the 1940s
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Europe, Ireland has estimated a case fatality rate of 3.2% in 1999. In the USA the Center
for Disease Control has published a case fatality rate of 10.5% and an incidence rate of
1 per 100,000 in 1999 [8]. In the African sub-Saharan countries endemic fatality rate are
between 2 and 20%, although during epidemics it can reach up to 70% or more [22]. Bacte-
rial meningitis, especially when caused by Neisseria meningitidis, can lead to death within
hours, if left untreated. That makes urgent medical attention mandatory. Since the possible
causes are many, the treatment differs for each. Patients are routinely started on intravenous
antibiotics immediately, often combined with anti-inflammatory corticosteroids.
The development of various types of vaccine started at the beginning of this century with
whole cell vaccines first and exotoxin vaccines later. The development of the first polysac-
charide vaccine started in 1935 and the first demonstration of a polysaccharide vaccine
being immunogenic in humans has been credited to Gotschlich in 1969. At present there is
a successful conjugate protein–polysaccharide vaccine in preventing haemophilus influen-
zae type b (Hib). Another vaccine available is the vaccine for meningococcal meningitis
strain C effective in children older than 18 months and with protection for 3–5 years. Also,
there is a vaccine for meningococcal meningitis strain A, but it is not recommended for
children under three months and the protection does not last more than 3 years. A tetrava-
lent polysaccharide vaccine (A,C,Y,W-135) is also available, but the antibody response and
persistence is age-dependent. Several Health Bodies do not recommend any of these vac-
cines for a routine childhood vaccination because of the irregularity of epidemics, the short
duration of protection and the high costs of immunization for developing countries. A new
immunization program for meningitis C has been initiated in some European countries in-
cluding Ireland and the UK. The vaccine is administered to children under the age of 5 and
young people aged 15–18 years.
To study the transmission dynamics of meningococcal infection we develop an age-
structured model and study the conditions for the stability of the disease-free steady state
and the existence of an endemic state. We use the results of the age-structured model to
identify the contribution of the carriers to the transmission of the disease.
This paper is organized as follows. Section 2 introduces the age-structured model. The
stability analysis of the disease-free steady state is presented in Section 3. In Section 4 we
study the conditions for existence and local stability of an endemic state. In Section 5 we
show that the dynamical system is uniformly persistent and has a global attractor. Thus,
we conclude that when the reproductive number is larger than one, the disease persists in
the population. Section 6 presents estimates of the average values of the parameters and
summarizes our conclusions based on the model.
2. The age-structured model
In the modeling of meningococcal infection transmission we consider three main fea-
tures.
(1) A significant presence of carriers. About 10% of the population at any time carry the
bacteria in the throat [6] for a period of time that can vary between 3 and 26 months.
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and young adults’ group.
(2) Infected individuals with or without symptoms do not become immune after recov-
ery. Infected individuals replenish the susceptible class. The replenishment occurs at
two different rates, one for carriers and one for regular infectious (those who become
infectious and develop the disease).
(3) There is a short period of immunity after birth. As a consequence of maternal antibody
transmission the newborn children are immune for an average period of 3 months.
We begin the presentation of the age-structured model by introducing our basic notation.
The population is divided into four classes of individuals: susceptibles, infecteds, carriers,
and temporarily immune (the last class consists of all newborn babies who are protected
by maternal antibodies approximately up to 3 months after birth). We denote those classes,
respectively, with the following age-structured functions: S(a, t), I (a, t),C(a, t),M(a, t).
We assume that all newborns are born immune and enter the susceptible class after loosing
their immunity at a rate d(a). We also assume that a susceptible individual may become
infected through contact with a carrier or a normal infectious individual. The susceptible
individuals move into the normal infectious class at a rate (1 − φ(a))λˆ(a, t), where (1 −
φ(a)) is the proportion of infections that develop the symptoms and λˆ(a, t) is the force of
infection (to be introduced later). If the infection does not develop, the new host becomes a
carrier at a rate φ(a)λˆ(a, t). The rates at which normal infectious and carriers recover are,
respectively, υ1(a) and υ2(a). Individuals can exit the system from any class at a mortality
rate µ(a). We assume that the disease-induced mortality rate can be neglected.
The dynamics of the age-structured model is defined by the following set of partial
differential equations:
Mt(a, t)+Ma(a, t)=−
(
d(a)+µ(a))M(a, t),
St (a, t)+ Sa(a, t)= d(a)M(a, t)−
(
µ(a)+ λˆ(a, t))S(a, t)
+ υ1(a)I (a, t)+ υ2(a)C(a, t),
It (a, t)+ Ia(a, t)=
(
1− φ(a))λˆ(a, t)S(a, t)− (υ1(a)+µ(a))I (a, t),
Ct (a, t)+Ca(a, t)= φ(a)λˆ(a, t)S(a, t)−
(
υ2(a)+µ(a)
)
C(a, t). (2.1)
We consider that system in conjunction with the following boundary and initial condi-
tions:
M(0, t)= b, S(0, t)= I (0, t)= C(0, t)= 0,
M(a,0)=M0(a), S(a,0)= S0(a), I (a,0)= I0(a), C(a,0)= C0(a),
where b is the recruitment rate, assumed constant. We denote the maximal age of the
population with a† and assume it is finite. The force of infection λˆ(a, t)= k(a)λ(t) [1,2]
identifies the net probability that a susceptible individual will acquire infection per unit
time. Here, λ(t) is
λ(t)=
a†∫
β(a)
I (a, t)+C(a, t)
N(a, t)
da, (2.2)
0
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contact with an infectious individual or a carrier of age a. We call λ(t) time component of
the force of infection and k(a) age component of the force of infection. Various hypothesis
can be considered about the infectiousness of the disease. It is possible to assume that inva-
sive meningitis is more contagious than carriage given that the symptoms are virulent. Also
some strains have greater pathogenicity than other which might also imply different levels
of infectiousness. On the other hand carriers stay infectious for long periods of time and
may be in contact with a relative high number of susceptibles, increasing their probability
of becoming infected. At this stage of our analysis we assume that carriers and normal
infectious have the same probability of transmitting the disease.
We would like to note that the force of infection in the age-structured case has many
forms. From the forms which are derived from the mass action law the two basic types
are the intracohort and the intercohort but also mixed intra-inter cohort and more general
cases have been considered (see [17] for a discussion). Forms of the proportional mixing
type involve form in which the normalization is made by the age-specific total population
density (as in our case) and in which normalization is by the total population (see, for
example, [4]).
The total population N(a, t) is given by
N(a, t)= S(a, t)+ I (a, t)+C(a, t)+M(a, t)
and it is governed by the following equations:
Nt(a, t)+Na(a, t)=−µ(a)N(a, t),
N(0, t)= b, N(a,0)=N0(a), (2.3)
where N(a,0)= S0(a)+ I0(a)+ C0(a)+M0(a)=N0(a). The system for the total pop-
ulation density can be solved explicitly,
N(a, t)=
{
be−
∫ a
0 µ(η) dη, a  t,
N0(a − t)e−
∫ a
a−t µ(η) dη, a > t.
(2.4)
Thus, the total population is at steady state for t > a and certainly for a† < t . We note
that although the force of infection is given by a homogeneous of degree zero expression,
model (2.1) as a whole is not homogeneous since the total birth rate b is constant. The as-
sumption of a constant birth rate is not unrealistic: constant birth rates have been estimated
in some European countries, such as Ireland and the UK, in the last decade. We assume the
parameters of the model satisfy the following conditions:
k(a),υ1(a), υ2(a),β(a)∈ L∞(0, a†),
φ(a) ∈ C[0, a†] and 0 < φ(a) < 1,
µ(a) ∈ L1loc(0, a†),
a†∫
µ(a) da =∞. (2.5)0
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must be unbounded so that the probability of being in the M class after a fixed age a†† is
zero. Thus, for d(a) we assume
a††∫
0
d(a) da =∞, a†† < a†.
Instead of system (2.1) throughout this article we will work with the normalized system.
We introduce the following fractions:
U(a, t)= S(a, t)
N(a, t)
, X(a, t)= I (a, t)
N(a, t)
,
Y (a, t)= C(a, t)
N(a, t)
, Z(a, t)= M(a, t)
N(a, t)
. (2.6)
We note that the proportions do not exceed one for any value of a and t . We can rewrite
system (2.1) as follows:
Zt(a, t)+Za(a, t)=−d(a)Z(a, t),
Ut (a, t)+Ua(a, t)= d(a)Z(a, t)− k(a)λ(t)U(a, t)+ υ1X(a, t)+ υ2Y (a, t),
Xt (a, t)+Xa(a, t)=
(
1− φ(a))k(a)λ(t)U(a, t)− υ1X(a, t),
Yt (a, t)+ Ya(a, t)= φ(a)k(a)λ(t)U(a, t)− υ2Y (a, t), (2.7)
with boundary conditionsZ(0, t)= 1, U(0, t)=X(0, t)= Y (0, t)= 0. The force of infec-
tion takes the form λˆ(a, t)= k(a)λ(t), where
λ(t)=
a†∫
0
β(a)
[
X(a, t)+ Y (a, t)]da. (2.8)
We introduce the following notation which we will use in the rest of the paper:
k1(a)=
(
1− φ(a))k(a), k2(a)= φ(a)k(a).
We note that k(a)= k1(a)+ k2(a).
In the next section we discuss the stability of the disease-free equilibrium and derive an
explicit expression forR0, the basic reproductive number of the infection.
3. Stability of the disease-free equilibrium
An equilibrium solution is a solution of system (2.7) which remains unchanged in time,
that is a time-independent solution. The disease-free equilibrium is population state in
which there are no infectious individuals. A steady state solution (Z(a),U(a),X(a),Y (a))
of system (2.7) must satisfy
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Ua(a)= d(a)Z(a)− λk(a)U(a)+ υ1X(a)+ υ2Y (a),
Xa(a)= λk1(a)U(a)− υ1X(a),
Ya(a)= λk2(a)U(a)− υ2Y (a),
Z(0)= 1, U(0)=X(0)= Y (0)= 0, (3.1)
where the time component of the force of infection at an equilibrium satisfies
λ=
a†∫
0
β(a)
[
X(a)+ Y (a)]da.
System (3.1) always has the disease-free steady state which is given by
Z0(a)= e−
∫ a
0 d(τ ) dτ ,
U0(a)=
a∫
0
d(τ)e−
∫ τ
0 d(σ ) dσ dτ = 1−Z0(a),
X0 = Y 0 = 0. (3.2)
To study the local stability of the disease-free equilibrium we linearize system (2.7)
about Eq. (3.2). Let z(a, t), u(a, t), x(a, t), y(a, t) be the perturbations of Z0,U0,X0, Y 0,
respectively. The perturbations satisfy the following system of equations:
zt (a, t)+ za(a, t)=−d(a)z(a, t),
ut (a, t)+ ua(a, t)= d(a)z(a, t)−Λ(t)k(a)U0(a)+ υ1x(a, t)+ υ2y(a, t),
xt (a, t)+ xa(a, t)= k1(a)Λ(t)U0(a)− υ1x(a, t),
yt (a, t)+ ya(a, t)= k2(a)Λ(t)U0(a)− υ2y(a, t), (3.3)
with boundary conditions z(0, t)= u(0, t)= x(0, t)= y(0, t)= 0. The perturbation of the
time component of the force of infection is given by
Λ(t)=
a†∫
0
β(a)
[
x(a, t)+ y(a, t)]da. (3.4)
We now consider exponential solutions of system (3.3) of the form
z(a, t)= z¯(a)eωt , u(a, t)= u¯(a)eωt ,
x(a, t)= x¯(a)eωt , y(a, t)= y¯(a)eωt .
The functions z¯, u¯, x¯, y¯ and the parameter ω satisfy the following system of equations:
z¯a(a)=−ωz¯(a)− dz¯(a),
u¯a(a)=−ωu¯(a)+ dz¯(a)− Λ¯k(a)U0 + υ1x¯(a)+ υ2y¯(a),
x¯a(a)=−ωx¯(a)+ Λ¯k1(a)U0 − υ1x¯(a),
y¯a(a)=−ωy¯(a)+ Λ¯k2(a)U0 − υ2y¯(a), (3.5)
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component of the force of infection we obtain
Λ¯=
a†∫
0
β(a)
[
x¯(a)+ y¯(a)]da. (3.6)
The equations for z¯, x¯ , and y¯ are self contained and can be solved. We note that z¯(a)= 0
for all a. We obtain expressions for x¯ and y¯,
x¯(a)= Λ¯
a∫
0
k1(τ )e
− ∫ aτ υ1(σ ) dσ e−ω(a−τ )U0(τ ) dτ,
y¯(a)= Λ¯
a∫
0
k2(τ )e
− ∫ aτ υ2(σ ) dσ e−ω(a−τ )U0(τ ) dτ, (3.7)
where U0 is given in (3.2). Substituting Eq. (3.7) into Λ¯ and dividing both sides by Λ¯ we
obtain the characteristic equation
a†∫
0
β(a)
a∫
0
[
k1(τ )e
− ∫ aτ υ1(σ ) dσ + k2(τ )e−
∫ a
τ υ2(σ ) dσ
]
e−ω(a−τ )U0(τ ) dτ da = 1.
(3.8)
Denote the expression in the left-hand side of (3.8) by F(ω). Now, we define the basic
reproductive number of the disease as R0 = F(0), or explicitly as
R0 =
a†∫
0
β(a)
a∫
0
[
k1(τ )e
− ∫ aτ υ1(σ ) dσ + k2(τ )e−
∫ a
τ υ2(σ ) dσ
]
U0(τ ) dτ da. (3.9)
We can now state the following theorem.
Theorem 3.1. The disease-free steady state (3.2) is locally asymptotically stable ifR0 < 1.
It is unstable if R0 > 1.
Proof. The function F(ω) is a decreasing and continuous function of ω which approaches
∞ when ω→−∞ and zero when ω→∞. Therefore the characteristic equation (3.8) al-
ways has a unique real solution ω∗. If F(0) < 1, or equivalently, R0 < 1, then the real
solution of F(ω) = 1 satisfies ω∗ < 0 and the unique real eigenvalue is negative. We
demonstrate later that the real parts of the other solutions of Eq. (3.8) are smaller than
the unique real solution of (3.8) and are therefore negative. Hence, the disease-free steady
state is locally asymptotically stable. To show that all complex solutions of F(ω) = 1
have real part smaller than ω∗, we consider an arbitrary complex solution of Eq. (3.8),
ω = α + γ i , where i is the imaginary unit. Since eω  eω and from Eq. (3.8) we know
that F(ω) = 1, F(ω) = 0, we derive that 1  F(ω). (Here  denotes the real part
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tion of ω, we conclude that ω ω∗. Hence, all complex solutions of (3.8) have real part
smaller than ω∗, the unique real solution. Thus, if R0 < 1, all eigenvalues of the charac-
teristic equation (3.8) have negative real part and the infection-free steady state is locally
asymptotically stable. On the other hand, if F(0) > 1, or equivalently,R0 > 1, the unique
real solution of (3.8) is positive, that is, ω∗ > 0 and therefore the infection-free state is
unstable. ✷
The reproductive numberR0 can be seen as a weighted value of the reproductive num-
ber of carrier infections and the reproductive number of normal infections. The key epi-
demiological parameters are the proportion of carriage infection, the duration of carriage,
the complementary proportion of normal infection, and the duration of normal infection.
As φ(a) varies with age [6] and specifically it has a small value in the children group and
a very high value in the teenager and young adult groups, the value of R0 of Eq. (3.8) de-
pends mainly on the basic reproductive number of normal infections in the children group
and in the basic reproductive number of carriage infection in the young adult group. When
R0 < 1, the number of infections decreases towards zero. The reproductive number R0
must exceed one for the disease to persist and remain endemic. In what follows we show
that if R0 < 1 the disease-free equilibrium is globally asymptotically stable, that is, that
the disease will die out no matter what its starting point is. The global stability of the
disease-free equilibrium is demonstrated in the following theorem.
Theorem 3.2. If R0 < 1 then the disease-free equilibrium (Z0(a),U0(a),0,0) is globally
asymptotically stable.
Proof. To prove the global stability of the disease-free equilibrium we have to show that
Z(a, t)→ Z0(a), U(a, t)→ U0, X(a, t)→ 0, Y (a, t)→ 0 as t →∞. In (2.7) we can
solve the equation for Z explicitly, and we can write X and Y in terms of U . We include
them here since we need them in the proof.
Z(a, t)=
{
e−
∫ a
0 d(τ ) dτ , a  t,
Z0(a − t)e−
∫ t
0 d(a−α) dα, a > t.
(3.10)
We note that Z(a, t) coincides with Z0(a) for all a  t . This observation plays impor-
tant role in our further considerations. Similar expression can be found for X and Y as
follows:
X(a, t)=


∫ a
0 k1(s)λ(t − a + s)e−
∫ a
s υ1(τ ) dτU(s, t − a + s) ds, a  t,
e−
∫ t
0 υ1(a−α) dαX0(a − t)
+ ∫ t0 k1(a − α)λ(t − α)e−
∫ α
0 υ1(α−σ) dσU(a − α, t − α)dα, a > t,
(3.11)
Y (a, t)=


∫ a
0 k2(s)λ(t − a + s)e−
∫ a
s υ2(τ ) dτU(s, t − a + s) ds, a  t,
e−
∫ t
0 υ2(a−α) dαY0(a − t)
+ ∫ t0 k2(a − α)λ(t − α)e−
∫ α
0 υ2(α−σ) dσU(a − α, t − α)dα, a > t.
(3.12)
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to obtain
λ(t)=
t∫
0
β(a)
a∫
0
[
k1(s)e
− ∫ as υ1(τ ) dτ + k2(s)e−
∫ a
s υ2(t) dt
]
× λ(t − a + s)U(s, t − a + s) ds da
+
a†∫
t
β(a)
[
X(a, t)+ Y (a, t)]da. (3.13)
Since X and Y do not exceed one, and the same is true for their sum, the last integral
can be estimated by
∫ a†
t β(a) da which decreases to zero as t increases to infinity. Notice
that
U(a, t)= 1−Z(a, t)−X(a, t)− Y (a, t)
 1−Z(a, t)= 1−Z0(a)=U0(a) for a < t. (3.14)
Considering Eqs. (3.13) and (3.14) we obtain
λ(t)
t∫
0
β(a)
a∫
0
[
k1(s)e
− ∫ as υ1(τ ) dτ + k2(s)e−
∫ a
s υ2(τ ) dτ
]
λ(t − a + s)U0(s) ds da
+
a†∫
t
β(a) da. (3.15)
Taking lim sup in time of both sides of the above equation we obtain
lim sup
t→∞
λ(t)R0 lim sup
t→∞
λ(t). (3.16)
As we assume thatR0 is strictly smaller than one, the only way inequality (3.16) can hold
is if
lim sup
t→∞
λ(t)= 0. (3.17)
Given this result, from expressions (3.11) and (3.12) we see that
lim sup
t→∞
X(a, t)= lim sup
t→∞
Y (a, t)= 0 (3.18)
pointwise in a. Furthermore, it is clear that Z(a, t)→ Z0(a) for t →∞ and from the
fact that X, Y , Z, and U add up to one, it follows that U(a, t)→ U0(a) for t →∞.
Therefore the disease-free equilibrium is globally asymptotically stable. The proof is now
completed. ✷
The global stability of the disease-free equilibrium implies that given a set of parameters
that satisfies R0 < 1, for any initial positive number of infections the number of carriers
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planning of disease control. If it is possible by vaccination, education or other preven-
tion programs to reduce the percentage of infections and carriers to a value that satisfies
R0 < 1, the disease can be eradicated. As mentioned in the Introduction, a new immu-
nization policy for meningococcal C has been introduced in Europe, particularly in Ireland
and the UK. This is the first of its kind as no previous vaccines were recommended for
routine childhood vaccination. As all vaccines are strain dependent, in order to introduce
vaccination in our model it would be important to introduce strain variations and genetic
structure. Preliminary considerations have been studied by the authors, but the complexity
of the genetic dynamics of the disease is beyond the scope of this paper.
In the next section we consider the existence of endemic points whenR0 > 1. We show
that at least one such point exists. The possibility for multiple endemic points remains
open.
4. Existence and linear stability of endemic equilibria
The endemic equilibrium is a time independent solution of (2.7) whose densities of
infected and/or infective individuals are nonzero. To show the existence of an endemic
state we have to show the existence of a solution of (3.1), (Z∗(a),U∗(a),X∗(a), Y ∗(a))
such that λ = 0, that is the transmission rate is not zero and the densities of the infecteds
and carriers are nonzero too. This result is summarized in the following theorem.
Theorem 4.1. If R0 > 1 then there exists an endemic equilibrium of (2.7).
Proof. Explicit solution for Z∗(a) can be found directly by integration
Z∗(a)= e−
∫ a
0 d(t) dt. (4.1)
Comparing this formula with (3.2) we see that Z is given by one and the same expres-
sion. Thus, the stable level of newborns, protected by maternal antibodies, is one and the
same whether the disease is present in the population or not. This observation, of course,
coincides with our intuitive expectation. As before we can express X∗ and Y ∗ in terms
of U∗,
X∗(a)= λ∗
a∫
0
k1(τ )e
− ∫ aτ υ1(σ ) dσU∗(τ ) dτ,
Y ∗(a)= λ∗
a∫
0
k2(τ )e
− ∫ aτ υ2(σ ) dσU∗(τ ) dτ. (4.2)
We can also express U∗(a) in terms of X∗ and Y ∗,
U∗(a)=
a∫
e−λ∗
∫ a
τ k(s) ds
[
d(τ)Z∗(τ )+ υ1(τ )X∗(τ )+ υ2(τ )Y ∗(τ )
]
dτ. (4.3)0
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of integration we obtain a Volterra integral equation for U∗,
U∗(a)=G(a)+
a∫
0
K(a,σ,λ∗)U∗(σ ) dσ, (4.4)
where we have introduced the following notation:
G(a)=
a∫
0
e−λ∗
∫ a
τ k(s) ds d(τ )Z∗(τ ) dτ, (4.5)
and K(a,σ,λ) is a sum of two kernels corresponding to the infective and carrier state
K1(a, σ,λ) and K2(a, σ,λ), respectively, which are defined by the following expressions:
K1(a, σ,λ
∗)= λ∗k1(σ )
a∫
σ
e−λ∗
∫ a
τ k(s) dsυ1(τ )e
− ∫ τσ υ1(s) ds dτ,
K2(a, σ,λ
∗)= λ∗k2(σ )
a∫
σ
e−λ∗
∫ a
τ k(s) dsυ2(τ )e
− ∫ τσ υ2(s) ds dτ.
The function K(a,σ,λ∗) is a Volterra kernel of continuous type and U∗(a) satisfies a
Volterra integral equation, namely (4.5), for each λ∗ and hence, depends on the choice
of λ∗. It is known from a result of Gripenberg et al. [15] that for every λ∗ there is a unique
solution of U∗(a,λ∗) which depends continuously on λ∗. We substitute the expressions of
X∗(a) and Y ∗(a) in the expression for λ in Eq. (3.1) (λ is in fact λ∗) and we cancel λ∗
(since it is not zero) to obtain
a†∫
0
β(a)
a∫
0
[
(k1(σ )e
− ∫ aτ υ1(σ ) dσ + k2(σ )e−
∫ a
τ υ2(σ ) dσ
]
U∗(τ ) dτ da = 1. (4.6)
We denote the left-hand side of (4.6) by H(λ∗). The function H depends on λ∗ trough
U∗(a,λ∗). If Eq. (4.6) has a positive solution, such that Z∗(a) + U∗(a) + X∗(a) +
Y ∗(a)= 1, then an endemic state exists. From our reasoning earlier it follows that H(λ∗)
is a continuous function of λ∗. Next, it is easy to see from (3.1) that U∗(a,0) is in fact U0
of the disease-free equilibrium (3.2). Hence, from (3.8) it follows that H(0)=R0. Since,
in this case R0 > 1, then H(0) > 1. On the other hand, for λ∗ > 0 we have
H(λ∗)= 1
λ∗
a†∫
0
β(a)
[
X∗(a)+ Y ∗(a)]da < 1
λ∗
a†∫
0
β(a) da. (4.7)
The expression on the right-hand side approaches zero as λ∗ approaches infinity. Hence,
the equation H(λ∗)= 1 has at least one solution with λ∗ > 0. Moreover, H(λ∗) < 1 for all
λ∗ 
∫ a†
0 β(a) da and therefore the solution to Eq. (4.6) is in the interval (0,
∫ a†
0 β(a) da).
This observation is important since the force of infection cannot exceed
∫ a† β(a) da. ✷0
M. Martcheva, G. Crispino-O’Connell / J. Math. Anal. Appl. 283 (2003) 251–275 263We note that the above theorem establishes existence of an endemic equilibrium. The
uniqueness or nonuniqueness remains an open problem (see also [7,9]).
In what follows we consider conditions for linear stability of an equilibrium. Let zˆ, uˆ,
xˆ, yˆ, and Λˆ be the perturbations of Z∗, U∗, X∗, Y ∗, and λ∗, respectively. We look for
exponential solutions in the system for the perturbations
zˆ= eλt z¯, uˆ= eλt u¯, xˆ = eλt x¯, yˆ = eλt y¯, and Λˆ= eλtΛ.
We obtain the following system:
u¯a =−λu¯− λ∗k(a)u¯−Λk(a)U∗ + υ1(a)x¯ + υ2(a)y¯,
x¯a =−λx¯ − λ∗k1(a)u¯+Λk1(a)U∗ − υ1(a)x¯,
y¯a =−λy¯ + λ∗k2(a)u¯+Λk2(a)U∗ − υ2(a)y¯, (4.8)
with initial conditions u¯(0)= x¯(0)= y¯(0)= 0. The trivial initial condition for z¯ leads to
z¯(a)= 0 for all a. The perturbation of the force of infection is given by
Λ=
a†∫
0
β(a)
(
x¯(a)+ y¯(a))da. (4.9)
We note that the functions u¯, x¯, y¯ can take on both positive and negative values. Assum-
ing Λ = 0 we set u= u¯/Λ, x = x¯/Λ, y = y¯/Λ and obtain the following system:
ua =−λu+ λ∗k(a)u− k(a)U∗ + υ1(a)x + υ2(a)y,
xa =−λx + λ∗k1(a)u+ k1(a)U∗ − υ1(a)x,
ya =−λy + λ∗k2(a)u+ k2(a)U∗ − υ2(a)y. (4.10)
Adding the three equations and taking into account the zero boundary condition we
obtain the following equation:
x + y + u= 0.
Using this identity we can reduce system (4.10) to a system in x and y ,
xa =−λx − λ∗k1(a)(x + y)+ k1(a)U∗ − υ1(a)x,
ya =−λy − λ∗k2(a)(x + y)+ k2(a)U∗ − υ2(a)y, (4.11)
with boundary conditions x(0)= y(0)= 0. The solution of (4.11) also satisfies the equa-
tion
a†∫
0
β(a)
[
x(a)+ y(a)]da = 1. (4.12)
Integrating (4.11) we obtain a system of integral equations in x and y ,
264 M. Martcheva, G. Crispino-O’Connell / J. Math. Anal. Appl. 283 (2003) 251–275x(a)=
a∫
0
e−λ(a−τ )e−λ∗
∫ a
τ k1(σ ) dσ e−
∫ a
τ υ1(σ ) dσ
[
k1(τ )U
∗(τ )− λ∗k1(τ )y(τ )
]
dτ,
y(a)=
a∫
0
e−λ(a−τ )e−λ∗
∫ a
τ k2(σ ) dσ e−
∫ a
τ υ2(σ ) dσ
[
k2(τ )U
∗(τ )− k2(τ )λ∗x(τ)
]
dτ.
(4.13)
Substituting the equation for y in the equation for x and the equation for x in the equa-
tion for y we obtain integral equations of Volterra type for x and y ,
x(a)=
a∫
0
e−λ(a−η)λ∗h1(a, η)x(η) dη+ f1(a),
y(a)=
a∫
0
e−λ(a−η)λ∗h2(a, η)y(η) dη+ f2(a), (4.14)
where the kernels h1 and h2 are nonnegative, independent of λ and are given by the ex-
pressions
h1(a, η)= λ∗k2(η)
a∫
η
e−λ∗
∫ a
τ k1(σ ) dσ e
−λ∗ ∫ τη k2(σ ) dσ e−
∫ a
τ υ1(σ ) dσ e
− ∫ τη υ2(σ ) dσ
× k1(τ ) dτ,
h2(a, η)= λ∗k1(η)
a∫
η
e−λ∗
∫ a
τ k2(σ ) dσ e
−λ∗ ∫ τη k1(σ ) dσ e−
∫ a
τ υ2(σ ) dσ e
− ∫ τη υ1(σ ) dσ
× k2(τ ) dτ, (4.15)
and the functions f1 and f2 are given by
f1(a)=
a∫
0
e−λ(a−η)g1(a, η)U∗(η) dη,
f2(a)=
a∫
0
e−λ(a−η)g2(a, η)U∗(η) dη, (4.16)
where we have used the following notation:
g1(a, η)= e−λ∗
∫ a
η k1(σ ) dσ e
− ∫ aη υ1(σ ) dσk1(η)− h1(a, η),
g2(a, η)= e−λ∗
∫ a
η k2(σ ) dσ e
− ∫ aη υ2(σ ) dσk2(η)− h2(a, η). (4.17)
Since x and y depend on λ, then the left-hand side of (4.12) is a function of λ. We denote
that function by Q(λ). In what follows we assume the following conditions are satisfied:
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for all 0  η  a  a†. We note that these conditions are similar to the extra condition
necessary for the local stability of the endemic equilibrium in an SIR model (see [18]).
Proposition 4.2. Assume inequalities (4.18). Then
(1) Q(λ) is a decreasing function of λ which tends to zero as λ tends to infinity;
(2) Q(0) < 1.
Proof. (1) The integral equations (4.14) can be solved
x(a)=
a∫
0
e−λ(a−η)G1(a, η)f1(η) dη+ f1(a),
y(a)=
a∫
0
e−λ(a−η)G2(a, η)f2(η) dη+ f2(a), (4.19)
where G1 and G2 are nonnegative functions independent of λ. Substituting in the expres-
sion for Q we obtain
Q(λ)=
a†∫
0
β(a)
a∫
0
e−λ(a−η)D(a,η)U∗(η) dη da, (4.20)
where the function
D(a,η)= g1(a, η)+ g2(a, η)+
a∫
η
G1(a, τ )g1(τ, η)+G2(a, τ )g2(τ, η) dτ
defined for 0  η  a  a† is nonnegative and independent of λ. Equation (4.20) clearly
shows that Q(λ) 0, that it is exponentially decreasing in λ and Q→ 0 as λ→∞.
(2) To show this part we use a different representation of Q. From system (4.10) one
can express x and y in terms of u,
x(a)=
a∫
0
e−λ(a−τ )e−
∫ a
τ υ1(σ ) dσk1(τ )
[
λ∗u+U∗(τ )]dτ,
y(a)=
a∫
0
e−λ(a−τ )e−
∫ a
τ υ2(σ ) dσk2(τ )
[
λ∗u+U∗(τ )]dτ. (4.21)
Substituting in Q and taking λ= 0 we obtain
Q(0)=
a†∫
β(a)
a∫ [
k1(τ )e
− ∫ aτ υ1(σ ) dσ + k2(τ )e−
∫ a
τ υ2(σ ) dσ
]
U∗(τ ) dτ da0 0
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a†∫
0
β(a)
a∫
0
[
k1(τ )e
− ∫ aτ υ1(σ ) dσ + k2(τ )e−
∫ a
τ υ2(σ ) dσ
]
λ∗u(τ) dτ da.
(4.22)
Equation (4.6) implies that the first integral above is exactly equal to one. Furthermore,
under assumption (4.18) we have x(a)+ y(a) 0 and therefore u 0. Hence the second
integral is negative. Therefore, Q(0) < 1. This completes the proof of the proposition. ✷
Proposition 4.2 and formula (4.20) imply that the equation Q(λ)= 1, which is equiva-
lent to (4.12), has a unique real solution which is negative and that all complex solutions
have real parts smaller than the unique real solution. Consequently, assumptions (4.18)
guarantee stability of the endemic equilibrium. We note that in the special case of equal
treatment rates υ1 = υ2 the system behaves as an age-structured SIS model and the en-
demic equilibrium is locally and possibly globally stable as long as the reproductive
numberR0 > 1. If the treatment rates are different, however, the system behaves as an age-
structured SIR model and the endemic equilibrium is locally stable only with additional
assumption which as in the SIR case guarantees that the perturbation(s) of all infectious
classes are nonnegative. One can expect that with certain values of the parameters oscilla-
tions are possible.
5. Persistence of the disease
In this section we discuss the problem of the persistence of the dynamical system. We
assume R0 > 1. Following the definitions in [16], we call system (2.7) persistent if
lim inf
t→∞
a†∫
0
X(a, t)+ Y (a, t) da > 0. (5.1)
System (2.7) is called uniformly persistent if there exists η > 0, independent of the initial
conditions, such that
lim inf
t→∞
a†∫
0
X(a, t)+ Y (a, t) da > η. (5.2)
Denote by
P(t)=
a†∫
0
X(a, t)+ Y (a, t) da.
We call P(t) the total proportion of infective people. We will show that
lim inf
t→∞
a†∫
β(a)
[
X(a, t)+ Y (a, t)]da > η. (5.3)0
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constant times the force of infection and, therefore, (5.3) implies (5.2). The uniform per-
sistence of the system implies that the disease remains endemic for large time. Denote by
n(a) the integral of the disease-free equilibrium, U0, n(a)= ∫ a0 U0(σ ) dσ . Choose 5 > 0
so that
a†∫
0
β(a)
a∫
0
[
k1(τ )e
− ∫ aτ υ1(σ ) dσ e−5
∫ a
τ k1(σ ) dσ + k1(τ )e−
∫ a
τ υ2(σ ) dσ e−5
∫ a
τ k2(σ ) dσ
]
× (U0(τ )− 5n(τ ))dτ da > 1. (5.4)
Inequality (5.4) is possible since for 5 = 0 the left-hand side above is equal to R0 and
we have assumed that R0 > 1. Therefore, for 5 small enough this inequality is still valid.
Consider the linear system
Xt (a, t)+Xa(a, t)= k1(a)λ(t)U0(a)− 5k1(a)
(X (a, t)+Y(a, t))− υ1X (a, t),
Yt (a, t)+Ya(a, t)= k2(a)λ(t)U0(a)− 5k2(a)
(X (a, t)+Y(a, t))− υ2Y(a, t),
X (0, t)= 0, Y(0, t)= 0,
X (a,0)=X0(a), Y(a,0)= Y0(a), (5.5)
where
λ(t)=
a†∫
0
β(a)
[X (a, t)+Y(a, t)]da.
Assume that in addition to inequality (5.4) epsilon is small enough so that the following
inequalities are valid for every 0 η a†:
(
1− φ(η)) 5a†k¯e5a†e∫ a†0 υ1(σ ) dσ ,
φ(η) 5a†k¯e5a†e
∫ a†
0 υ2(σ ) dσ , (5.6)
where
k¯ = sup
a∈(0,a†)
k(a).
We note that it is possible to chose such 5 since φ and 1− φ are bounded below by a pos-
itive constant. We first show that the linear system (5.5) exhibits balanced (asynchronous)
exponential growth [21].
Proposition 5.1. Let R0 > 1. Assume inequalities (5.6) are valid with 5 satisfying (5.4).
Then system (5.5) exhibits balanced (asynchronous) exponential growth with positive
growth constant.
Proof. To see this we apply Proposition 2.3 in [21]. We will assume that the solutions to
(5.5) form a C0-semigroup on L1 with generator A. First, we begin by showing that the
dominant eigenvalue of A is real, positive, and any other eigenvalue has a smaller real
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consider the following eigenvalue problem:
Xˆa(a)=−rXˆ (a)+ k1(a)U0(a)− 5k1(a)
(Xˆ (a)+ Yˆ(a))− υ1(a)Xˆ (a),
Yˆa(a)=−rYˆ(a)+ k2(a)U0(a)− 5k2(a)
(Xˆ (a)+ Yˆ(a))− υ2(a)Yˆ(a),
Xˆ (0)= 0, Yˆ(0)= 0, (5.7)
where we have normalized by the corresponding value of λ so that we have
a†∫
0
β(a)
[Xˆ (a)+ Yˆ(a)]da = 1. (5.8)
System (5.7) is similar to system (4.11) with 5 instead of λ∗ and U0 instead of U∗.
Therefore, we can treat it with similar techniques. In particular, we can integrate equations
in (5.7) assuming Yˆ(a) as given in the equation for Xˆ (a) and vice versa. Then, we sub-
stitute the expression for Yˆ(a) in the equation for Xˆ (a) thus obtaining a Volterra integral
equation for Xˆ (a). Similarly, we can obtain a Volterra integral equation for Yˆ(a). Solving
these equations we obtain the following expressions for Xˆ (a) and Yˆ(a):
Xˆ (a)=
a∫
0
e−r(a−η)H1(a, η) dη,
Yˆ(a)=
a∫
0
e−r(a−η)H2(a, η) dη, (5.9)
where H1(a, η) and H2(a, η) are given functions which do not depend on r . Conditions
(5.6) guarantee that H1(a, η) and H2(a, η) are nonnegative. We can substitute expressions
(5.9) in the left-hand side of Eq. (5.8). Thus, we obtain a function of r . We denote this
function by Q(r).
Q(r)=
a†∫
0
β(a)
a∫
0
e−r(a−η)H(a,η) dη da,
where H(a,η)=H1(a, η)+H2(a, η). Clearly, Q(r) is a decreasing function of r and the
equation Q(r)= 1 has a unique real solution. Observe that
Q(0)=
a†∫
0
β(a)
a∫
0
[
k1(τ )e
− ∫ aτ υ1(σ ) dσ e−5
∫ a
τ k1(σ ) dσ
+ k2(τ )e−
∫ a
τ υ2(σ ) dσ e−5
∫ a
τ k2(σ ) dσ
](
U0(τ )− 5n(τ ))dτ da. (5.10)
Hence, from assumption (5.4) it follows that Q(0) > 1 and, therefore, the unique real
solution r0 of the equation Q(r)= 1 is positive. Moreover, a standard argument can show
that all complex solutions have smaller real parts. Consequently, r0 is the dominant eigen-
value. Furthermore, system (5.7) has a unique solution given by (5.9) with r = r0 which
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ω1(A) r0, where the meaning of ω1(A) is as in [21]. To see this we apply Proposition 2.4
in [21]. We represent the solution as a sum of two solutions X (a, t)= X˜ (a, t)+ X¯ (a, t),
Y(a, t)= Y˜(a, t)+ Y¯(a, t). The bar functions satisfy
X¯ (a, t)=


∫ a
0 e
− ∫ aτ υ1(σ ) dσ e−5
∫ a
τ k1(σ ) dσk1(τ )
× [λ¯(t − τ )U0(a − τ )− 5Y¯(a − τ, t − τ )]dτ, a  t,
0, a > t,
Y¯(a, t)=


∫ a
0 e
− ∫ aτ υ2(σ ) dσ e−5
∫ a
τ k2(σ ) dσk2(τ )
× [λ¯(t − τ )U0(a − τ )− 5X¯ (a − τ, t − τ )]dτ, a  t,
0, a > t,
(5.11)
where
λ¯(t)=
a†∫
0
β(a)
[X¯ (a, t)+ Y¯(a, t)]da.
For a fixed t1 > a† we show that the set of functions (X¯ (a, t1), Y¯(a, t1)) is compact.
First, denote by L¯ the maximum of λ¯(t) over the interval [0, t1]. Next, the following in-
equalities can be verified:
‖X¯ ‖L1 + ‖Y¯‖L1  C1, ‖X¯a‖L1 + ‖Y¯a‖L1  C2,
where C1 and C2 are constants which depend on L¯, and therefore, on t1. By Kolmogorov’s
principal of compactness in L1 we conclude that the set is precompact in L1. Next, the
tilde functions satisfy
X˜ (a, t)=


0, a  t,
X0(a − t)e−
∫ a
0 υ1(σ ) dσ e−5
∫ a
0 k1(σ ) dσ
+ ∫ t0 e−
∫ a
τ υ1(σ ) dσ e−5
∫ a
τ k1(σ ) dσk1(τ )
× [λ˜(t − τ )U0(a − τ )− 5Y˜(a − τ, t − τ )]dτ, a > t,
Y˜(a, t)=


0, a  t,
Y0(a − t)e−
∫ a
0 υ2(σ ) dσ e−5
∫ a
0 k2(σ ) dσ
+ ∫ t0 e−
∫ a
τ υ2(σ ) dσ e−5
∫ a
τ k2(σ ) dσk2(τ )
× [λ˜(t − τ )U0(a − τ )− 5X˜ (a − τ, t − τ )]dτ, a > t,
(5.12)
where
λ˜(t)=
a†∫
0
β(a)
[X˜ (a, t)+ Y˜(a, t)]da.
Integrating both sides of the equations for X˜ and Y˜ , using Gronwall’s inequality and
taking into account that X˜ and Y˜ are nonzero only when t  a†, we establish the following
inequality:
∥∥X˜ (·, t)∥∥ 1 + ∥∥Y˜(·, t)∥∥ 1 K(‖X0‖L1 + ‖Y0‖L1), (5.13)L L
270 M. Martcheva, G. Crispino-O’Connell / J. Math. Anal. Appl. 283 (2003) 251–275where K is a constant. Inequality (5.13) is trivially valid for t > a†. Therefore, Proposi-
tion 2.4 in [21] implies ω1(A) 0. Consequently, since r0 > 0 we have
ω1(A) < r0.
Proposition 2.3 in [21] now implies that system (5.5) exhibits balanced (asynchronous)
exponential growth. This completes the proof. ✷
In what follows we show that the solutions are uniformly persistent and have a global
attractor. First, we introduce some useful definitions. Let X be a complete metric space
and T (t) :X→X be a C0-semigroup. Following the definitions in [14] an invariant set A
is said to be a global attractor if A is a maximal compact invariant set which attracts each
bounded set in X. A semigroup T (t) is called point dissipative if there is a bounded set in
X that attracts each point of X under T (t). A semigroup T (t) is completely continuous for
t  t1 if, for each t  t1, the image of each bounded set under T (t) is precompact. Let
X = {f (a) ∈L1(0, a†)×L1(0, a†)×L1(0, a†): 0 f (a) 1}.
Assume (this can be proved with standard techniques) that the solutions of (2.7) form
a C0-semigroup of bounded operators T (t). The following proposition shows that this
semigroup is completely continuous.
Proposition 5.2. The semigroup T (t) is completely continuous for t > a†.
Proof. We show that the set of solutions of (2.7) is precompact in X. To show that, fix
t1 > a† and consider the set of functions f (a)= (U(a, t1),X(a, t1), Y (a, t1)) which satisfy
integral equations (3.11) and (3.12). First we note that it is bounded,
‖f ‖X  C1.
Next, it is not hard to see that the set of derivatives is bounded,
‖fa‖X  C2.
Therefore, by Kolmogorov’s criterion for compactness in L1, the set of solutions is pre-
compact. This completes the proof. ✷
Next we show that the dynamical system produced by the solutions of (2.7) has a global
attractor.
Proposition 5.3. The semigroup T (t) has a nonempty global attractor A in X.
Proof. To apply Theorem 3.4.8 in [14, p. 40] we need to show that T (t) is completely
continuous and point dissipative. Clearly, any attractor of the dynamical system induced
by the solutions of (2.7) is bounded. Thus, T (t) is point dissipative. Proposition 5.2 implies
that T (t) is completely continuous. This completes the proof. ✷
Finally, we show that the semigroup generated by the solutions of (2.7) is uniformly
persistent. In particular, we have
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Proof. We apply Theorem 4.1 in [16]. This result has been applied before to establish
uniform persistence of an epidemiological model in [20]. Proposition 5.2 above implies
that the semigroup of solutions of system (2.7) is compact. Since the solutions are bounded,
it is clear that the semigroup is point dissipative. We take the boundary of X consisting
of all triples (U,0,0). In this case the semigroup of solutions can be restricted to the
boundary (see (3.1) in [16]). All solutions that start on the boundary stay on the boundary
and converge to the disease-free equilibrium. Hence, the attractor on the boundary consists
of the disease-free equilibrium and is isolated. We can pick M to consist of one set, namely
the disease-free equilibrium. It remains to be shown that the stable manifold of the disease-
free equilibrium does not contain points from the interior. In other words, it remains to be
shown that no solution that starts from a point in which not both X0 and Y0 are zero
converges to the disease-free equilibrium. To see this, assume there exists a solution, such
that X0 = 0 and/or Y0 = 0 but
lim
t→∞
a†∫
0
X(a, t)+ Y (a, t) da = 0. (5.14)
This also implies that
lim
t→∞
a†∫
0
β(a)
[
X(a, t)+ Y (a, t)]da = 0.
Then, for every 5 there exists T5 such that
a†∫
0
β(a)
[
X(a, t)+ Y (a, t)]da  5
for all t  T5 . Assume without loss of generality that T5  a†. Choose 5 so that inequalities
(5.4) and (5.6) are satisfied. Proposition 5.1 implies that system (5.5) exhibits balanced
exponential growth with positive growth constant r0. Let (X ,Y) be a solution of (5.5)
satisfying
X(a,T5)=X (a, T5), Y (a,T5)= Y(a, T5).
Then, for t  T5 we have
X(a, t)X (a, t), Y (a, t) Y(a, t).
Since (5.5) exhibits balanced exponential growth, there exists a pair (Xˆ (a), Yˆ(a)) such
that for every δ, there exists Tδ such that for every t  Tδ we have∥∥e−r0tX (·, t)− Xˆ∥∥
L1 +
∥∥e−r0tY(·, t)− Yˆ∥∥
L1  δ.
Then, for t max(T5, Tδ) we have
er0t
(‖Xˆ ‖L1 − δ) ∥∥X (·, t)∥∥L1 
∥∥X(·, t)∥∥
L1,
er0t
(‖Yˆ‖L1 − δ) ∥∥Y(·, t)∥∥ 1  ∥∥Y (·, t)∥∥ 1 . (5.15)L L
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Inequalities (5.15) imply that the norms of X and/or Y grow exponentially which is a
contradiction with our assumption (5.14). This completes the proof. ✷
6. Discussion
In this paper we introduce an age-structured model of meningococcal meningitis with
two disease-related classes: normal infectives (infecteds who exhibit symptoms and effec-
tively are ill) and carriers (infecteds who have the bacteria but appear healthy). Both the
normal infectives and carriers are assumed to be able to transmit the disease with indis-
tinguishable contact rates and probability of transmission. However, we assume different
treatment rates for the two classes. We compute explicitly the reproductive numberR0 of
the disease which, in fact, is a sum of two reproductive numbers: one that corresponds to
the secondary infections generated by an infective individual and one that corresponds to
the secondary infections generated by a carrier. We show that if R0 < 1, there is a unique
equilibrium, namely the infection-free equilibrium and it is globally asymptotically stable.
This leads to the conclusion that if the parameters satisfy the condition R0 < 1, the dis-
ease dies out. On the other hand, if the opposite inequality is satisfied, there are at least
two equilibria: the infection-free equilibrium and an endemic equilibrium. In fact, we have
not been able to prove that the endemic equilibrium is unique. Theoretically it is possible
that there are more than one endemic equilibria. Each equilibrium can be computed as a
solution of a Volterra integral equation. In the case R0 > 1 the infection-free equilibrium
is unstable which means that it attracts only those solutions which start from an infection-
free state. We have derived conditions for the local stability of an endemic equilibrium.
In general, the system may admit oscillations. We also show that in the case R0 > 1 the
dynamical system is uniformly persistent and has a global attractor which implies that if
the parameters satisfy this inequality, the disease persists in the population.
It is clear to the authors that our conclusions would be strongly enhanced by the esti-
mation of the model parameters and the simulation of the infection dynamics. Preliminary
work in this area has been undertaken using sources from Ireland and the UK [6,10–13].
Estimating the proportion of infections that become carriers, we take into account the fact
that it is assumed that 10% of the population are carriers at any time. This figure applied
to the average population of Ireland from 1980 and 1998 results on average of 350,000
carriers every year. Comparing this value with the average number of normal infections
per year we derive a value for φ of about 95–99% or φ = 0.95 to φ = 0.99. It should
be noted that this average estimate of the proportion of infections that become carriers is
too rough. Our preliminary simulations suggest that each point increase or decrease leads
to substantial change in the reproductive number and the equilibrium number of infec-
tives and carriers. To estimate the force of infection from incidence data one can use the
methodology described in [3]. In this case our simulations suggest that the reproductive
number and the number of invectives and carriers in the equilibrium depend very little on
the shape, age-support, and even the magnitude of β(a). Thus, we assume that constant β
will lead to similar simulation and dynamic results and it provides a good approximation
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of infection at equilibrium (we take k(a)= 1)
λ= β
a†∫
0
[
X∗(a)+ Y ∗(a)]da
and we derive the value of λ from the average age at infection A [1],
A≈ 1
λ+µ, (6.1)
where µ= 0.013 yr−1. Considering the data collected by Fogarty and Moloney [10] in re-
lation to the age-related spread of infection in Ireland in 1995 and the data published on the
age distribution of the carriage infection [6], an approximated average age at infection is 12
years old. This has been calculated as the weighted mean of the average age at infection for
the normal infectious individuals who become sick and the average age at infection for the
carriers. Thus, λ= 0.07. Considering an average value of ∫ a†0 X∗(a) da and ∫ a†0 Y ∗(a) da,
respectively, 0.00025 and 0.1, estimated as average proportion of infections, we derive an
approximate value of β = 0.7. Summarizing the data for Western European countries, it
seems realistic to estimate that the average duration of infection for normal infectives is
about 3 to 4 weeks. Therefore, an average (age-independent) value of υ1 can be estimated
as υ1 = 26 yr−1. On the contrary, information on the average duration of carriage seems
to be incomplete given the difficulties in the design and interpretation of the trials. Most
of the studies on the prevalence of meningococcal carriage have been done with repeated
swabbing samples of the same individuals for a certain period of time. Usually carriers are
enrolled at the beginning of the study and followed until the carrier state is terminated. It
is clear that there is no possibility to estimate the duration of carriage prior to the time of
enrollment. Therefore any estimation should be considered a minimal figure. In general, it
is assumed that the average duration of carriage is about 10–14 months. Several publica-
tions suggest the existence of long-term and short-term carriers. Even though the biological
reasons are still unknown, it seems that some individuals become carriers for a short pe-
riod of time (a month or two) while others stay carriers for longer (30–36 months). Given
these considerations we consider two average duration of infection: short term carriers, for
which υ2 = 12 yr−1 and long term carriers, for which υ2 = 0.4 yr−1.
Different treatment rates in normal infectives and carriers can lead to a potentially very
different dynamics. In particular, if the treatment rates are the same, then there is a unique
endemic equilibrium which is globally asymptotically stable. Although we did not prove
this rigorously, it is a direct consequence of the fact that the model in this case reduces to
an age-structured SIS model for which it is known that the endemic equilibrium is glob-
ally stable [5]. In the case when the treatment rates are different, we observe behavior
similar to an SIR model. Namely, there are additional conditions which guarantee the lo-
cal stability of the endemic equilibrium. If these conditions are not satisfied it is possible
that the model exhibits oscillations. In fact, the oscillations in the model are somewhat
in agreement with dynamics observed in practice. Indeed, the disease is endemic in most
countries and is represented by a steady number of sporadic cases. However, in a number
of countries of sub-Saharan Africa, which form a region called the “meningitis belt” (it
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mirrors oscillations: relatively low endemic levels of the disease lasting eight to twelve
years are followed by epidemics cycles lasting for two–three consecutive years. For ex-
ample, Sudan has had major outbreaks of meningococcal meningitis in 1977–1980 and
1988–1991. In each of these outbreaks the number of cases peaked at 30000 [22]. Epi-
demics usually spread rapidly and peak within weeks but the incidence rates remain high
in the following one–two years unless at least 80% of the entire population is vaccinated.
The facts presented by the WHO suggest that unless mass immunization is carried out the
periods of relatively low incidence are followed by substantial outbreaks, and then again
by a period of relatively low incidence. Consequently, if our model exhibits oscillations,
it reflects adequately reality. If model (2.7) displays oscillations, they can be obtained via
Hopf bifurcation and appear to be due to the presence of age-structure.
Parallelly to the age-structured model, we considered an ODE model which can be
obtained from the PDE model by assuming the parameters to be constant and taking an
incidence term of proportionate mixing type. In the ODE case there is a unique endemic
equilibrium which can be explicitly computed. In addition, it is possible to show that the
endemic equilibrium is locally stable whenever it exists. This opens the door for showing
its global stability which, in turn, rules out oscillations.
In this simple model of an infection with carrier stage we see that no endemic state
where infectives or carriers are not present is possible. This suggests that it is enough in
practice to monitor one of the groups; the other one has a consistent behavior. Certainly, the
group that is easier and more worthwhile monitoring is the group of infectives. Clearly, this
observation somewhat contrasts our intuition that for diseases with a carrier stage, carriers
may be present even if there are no infectives, and that carriers serve as a reservoir from
which the disease can reappear even after it has been conquered.
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